PRGO Q4 2023 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q4 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B+0.1% YoY

Gross Profit

$427M36.9% margin

Operating Income

-$16M-1.3% margin

Net Income

-$32M-2.8% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+2.9%

Cash Flow

Operating Cash Flow

$209M

Free Cash Flow

$182M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$10.8B

Total Liabilities

$6.0B

Stockholders' Equity

$4.8B

Cash & Equivalents

$751M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	+0.1%
Gross Profit	$427M	$383M	+11.7%
Operating Income	-$16M	$31M	-150.3%
Net Income	-$32M	-$24M	-36.3%

Revenue Segments

Consumer Self-Care Americas

$744M64%

Consumer Self-Care International

$413M36%

Geographic Segments

UNITED STATES

$741M63%

Europe

$390M33%

Other Geographical Areas

$27M2%

IRELAND

$10M1%